BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21308671)

  • 1. [High alpha-fetoprotein persistence after orchiectomy. On a case of uncommon etiology].
    Chierigo P; Puccetti O; Visonà A; Bassan F; Rahmati M; Lazzarotto M; Franzolin N
    Urologia; 2010; 77 Suppl 17():27-31. PubMed ID: 21308671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary persistence of alpha-fetoprotein. Case report and review of the literature.
    Schefer H; Mattmann S; Joss RA
    Ann Oncol; 1998 Jun; 9(6):667-72. PubMed ID: 9681083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary persistence of alpha-fetoprotein.
    Li X; Alexander S
    Pediatr Blood Cancer; 2009 Mar; 52(3):403-5. PubMed ID: 18985745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. If AFP is elevated, where is cancer? The case report on hereditary persistence of Alpha-fetoprotein.
    Saracoglu H; Baskol M; Saracoglu H; Baskol G
    Malawi Med J; 2022 Dec; 34(4):291-293. PubMed ID: 38125776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two cases of testicular tumors with high alpha-fetoprotein levels: a case report].
    Funahashi M; Tuchiya F; Makiyama K; Sugiura S; Miyoshi Y; Kishida T; Ogawa T; Uemura H; Yao M; Kubota Y
    Hinyokika Kiyo; 2005 Feb; 51(2):133-7. PubMed ID: 15773370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary Persistence of Alpha-Fetoprotein in Chronic Liver Disease-Confusing Genes!
    Patil V; Jothimani D; Narasimhan G; Danielraj S; Rela M
    J Clin Exp Hepatol; 2021; 11(5):616-618. PubMed ID: 34511823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary persistence of alpha-fetoprotein (HPAF P): review of the literature.
    Houwert AC; Giltay JC; Lentjes EG; Lock MT
    Neth J Med; 2010 Nov; 68(11):354-8. PubMed ID: 21116028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors.
    Kamoto T; Satomura S; Yoshiki T; Okada Y; Henmi F; Nishiyama H; Kobayashi T; Terai A; Habuchi T; Ogawa O
    Jpn J Clin Oncol; 2002 Nov; 32(11):472-6. PubMed ID: 12499420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of hereditary persistence of α-fetoprotein: diagnostic usefulness of the subfraction profile.
    Waseda Y; Tanaka H; Nakagomi K; Goto S; Ido A
    Jpn J Clin Oncol; 2012 Aug; 42(8):767-9. PubMed ID: 22689918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
    Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
    J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary persistence of alpha-fetoprotein mimicking testicular cancer in a patient with acute epididymitis.
    Abt D; Meier M; Markart P; Schmid HP
    Scand J Urol Nephrol; 2011 Nov; 45(5):354-5. PubMed ID: 21446891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
    Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
    Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lectin-reactive alpha-fetoprotein as a marker for testicular tumor activity.
    Kawai K; Kojima T; Miyanaga N; Hattori K; Hinotsu S; Shimazui T; Akaza H
    Int J Urol; 2005 Mar; 12(3):284-9. PubMed ID: 15828957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of yolk sac tumor of the testis with hydrocele in children: report of 7 cases].
    Huang SS; Wu DL; Gui YP; Zhao X; Xie H
    Zhonghua Nan Ke Xue; 2013 Nov; 19(11):1007-10. PubMed ID: 24341096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure Testicular Seminoma with Non-Pathologic Elevation of Alpha Fetoprotein: A Case Series.
    Dieckmann KP; Anheuser P; Simonsen H; Höflmayer D
    Urol Int; 2017; 99(3):353-357. PubMed ID: 28668957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD; Foster RS; Bihrle R; Donohue JP
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
    Iwatsuki S; Naiki T; Kawai N; Etani T; Iida K; Ando R; Nagai T; Okada A; Tozawa K; Sugiyama Y; Yasui T
    J Med Case Rep; 2016 May; 10(1):114. PubMed ID: 27150447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of spermatic cord teratoma in low-stage testicular cancer managed by surveillance.
    Subramanian VS; Gilligan T; Klein EA
    Nat Clin Pract Urol; 2008 Apr; 5(4):220-3. PubMed ID: 18268549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yolk sac tumors and alpha-fetoprotein in first year of life.
    Brewer JA; Tank ES
    Urology; 1993 Jul; 42(1):79-80. PubMed ID: 7687081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.